ArticleBMC pediatrics2026
Epidemiological characteristics of measles in children in Togo from 2020 to 2024: a cross-sectional study.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn Togo, despite efforts to achieve optimal vaccination coverage, measles continues to be prevalent in the country. The objective of this study was to describe the epidemiological, diagnostic, and preventive aspects of measles in children.
methodsThis was a cross-sectional study of measles data from 2020 to 2024 in Togo among children under 18 years of age. The measles database of the “Institut National d’Hygiène” was used for the study. It was a secondary analysis of national measles surveillance data. A time, place, and person analysis was performed.
resultsA total of 3,135 suspected cases were recorded. There were 1,251 confirmed cases. The confirmation rate was 39.9% (CI 38.2–41.6%) with 3 deaths among confirmed cases. The median age was 3.7 years (IQR 1.9–6.0) for confirmed cases. The sex-ratio was 1.03 among confirmed cases. A higher proportion of confirmed cases was observed among females compared to males (42.0% vs. 37.8%, p = 0.016). In rural areas 707 cases were confirmed, compared with 397 cases in urban areas. The number of confirmed cases was highest in the Maritime and the Plateaux regions, with 380 and 352 cases respectively (p < 0.001). Most confirmed cases were notified in the years 2022 and 2023 with 619 and 444 cases respectively (p < 0.001). The frequency of confirmed cases was lower among vaccinated suspected cases compared to unvaccinated suspected cases (p < 0.001).
conclusionMeasles confirmed cases was highest in the Maritime and the Plateaux regions and the frequency of confirmed cases was lower among vaccinated suspected cases. Response measures and awareness campaigns to improve vaccination coverage are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.